Opdivo Nivolumab 40mg / 4Ml Infusion

40mg / 4Ml Infusion , Vial

4.5 (154)

15,000

Opdivo 40mg Injection is an immunotherapy medicine used to treat several types of cancer, including non-small cell lung cancer, melanoma, renal cell carcinoma, Hodgkin lymphoma, and head and neck cancer. It is a monoclonal antibody that blocks the PD-1 receptor on T-cells, helping the immune system recognize and attack cancer cells. Common side effects include fatigue, nausea, diarrhea, reduced appetite, and skin rash.

Description

Introduction Of Opdivo 40mg Injection:

An immunotherapy medicine called nivolumab is used to treat cancer. It is a monoclonal antibody that specifically targets the T-cells’ PD-1 receptor, which can boost immune responses against cancer cells.

Uses Of Opdivo 40mg Injection:

Nivolumab is used to treat several types of cancer, including:

  • Non-small cell lung cancer
  • Melanoma
  • Renal cell carcinoma
  • Hodgkin’s lymphoma
  • Head and neck squamous cell carcinoma

Moa:

Opdivo 40mg Injection is a monoclonal antibody that specifically targets the T-cells’ PD-1 receptor. Immune system tolerance depends on the inhibition of T-cell activity, which is what the PD-1 receptor does. By increasing PD-1 expression on T-cells, cancer cells can occasionally avoid immunological responses, depleting T-cells and lowering immune activity. Nivolumab can boost T-cell activation against cancer by inhibiting PD-1.

Side Effect Of Opdivo 40mg Injection:

Opdivo 40mg Injection most frequent side effects are exhaustion, nausea, lack of appetite, diarrhoea, and skin rashes.

Infusion responses can be quite harmful, resulting in symptoms like low blood pressure, chills, fever, and shortness of breath. Any side effects must be reported right once to your healthcare physician.

Overall, nivolumab has proven to be successful in treating a number of cancer types. However, it’s crucial to go over any potential advantages and hazards with your doctor before starting therapy.

Contact Us

Info Table
Composition Nivolumab
Prescription/Non prescription Non prescription
Storage 1 month at 2-8 DegreeC and 7 days at 40 DegreeC.
Strength 10 Mg
Manufacturer Cipla
Brand Opdivo
Packaging Size 40 Mg/ 4 Ml
Package Type Vial
Treatment skin cancer treatment
Vendor Info
Benefits
Reviews

Description

Introduction Of Opdivo 40mg Injection:

An immunotherapy medicine called nivolumab is used to treat cancer. It is a monoclonal antibody that specifically targets the T-cells’ PD-1 receptor, which can boost immune responses against cancer cells.

Uses Of Opdivo 40mg Injection:

Nivolumab is used to treat several types of cancer, including:

  • Non-small cell lung cancer
  • Melanoma
  • Renal cell carcinoma
  • Hodgkin’s lymphoma
  • Head and neck squamous cell carcinoma

Moa:

Opdivo 40mg Injection is a monoclonal antibody that specifically targets the T-cells’ PD-1 receptor. Immune system tolerance depends on the inhibition of T-cell activity, which is what the PD-1 receptor does. By increasing PD-1 expression on T-cells, cancer cells can occasionally avoid immunological responses, depleting T-cells and lowering immune activity. Nivolumab can boost T-cell activation against cancer by inhibiting PD-1.

Side Effect Of Opdivo 40mg Injection:

Opdivo 40mg Injection most frequent side effects are exhaustion, nausea, lack of appetite, diarrhoea, and skin rashes.

Infusion responses can be quite harmful, resulting in symptoms like low blood pressure, chills, fever, and shortness of breath. Any side effects must be reported right once to your healthcare physician.

Overall, nivolumab has proven to be successful in treating a number of cancer types. However, it’s crucial to go over any potential advantages and hazards with your doctor before starting therapy.

Contact Us

Reviews

There are no reviews yet.

Be the first to review “Opdivo Nivolumab 40mg / 4Ml Infusion”

Your email address will not be published. Required fields are marked *

Frequently Asked Questions

From sourcing to delivery, we ensure reliability at every step. Our operations follow strict quality and regulatory standards.

What is Opdivo 40mg Injection?
Opdivo 40mg Injection contains nivolumab, a monoclonal antibody used in cancer immunotherapy. Nivolumab works by helping the immune system recognize and slow or stop the growth of certain cancer cells. It is administered under the supervision of a qualified healthcare professional.
Opdivo (nivolumab) is used to treat several types of cancer, depending on the patient’s condition and treatment protocol. It may be used alone or in combination with other anticancer medicines for certain cancers. The specific indication should be determined by the treating oncologist.
Opdivo 40mg Injection is administered intravenously by a doctor or nurse in a hospital, clinic, or infusion facility. Nivolumab is generally given over approximately 30 minutes, with the treatment frequency determined by the patient’s condition and response to therapy.
Patients should inform their healthcare provider about autoimmune diseases, lung or breathing problems, thyroid, kidney or liver conditions, previous organ or stem-cell transplantation, chest radiation, allergies, pregnancy or breastfeeding, and all medicines or supplements they are taking. Regular medical and laboratory monitoring may be required during treatment.
Possible side effects may include tiredness, muscle or joint pain, skin changes, digestive symptoms, and changes in appetite or taste. Nivolumab can also cause serious immune-related reactions affecting organs such as the lungs, liver, kidneys, intestines, skin, or endocrine glands. Infusion-related reactions can also occur and should be reported immediately.
For additional information about nivolumab, including its uses, administration, precautions, interactions, and possible side effects, visit MedlinePlus Drug Information. Patients should consult their oncologist or healthcare professional for advice specific to their treatment.

Related products